Inari Medical Corp (NARI): יחס שווי פעילות לרווח לפני ריבית, מסים ופחת

Inari Medical, Inc. (NARI) generates revenue from the supply of thrombectomy tools, which have become firmly established in vascular surgery due to their high efficacy. Business growth is driven by the implementation of FlowTriever systems and expansion into global markets. This EV/EBITDA chart captured the metric at . Patent protection and FDA certification, combined with staff training, create significant barriers to entry for new players.

Inari Medical, Inc. (NARI) generates profit through high-tech mechanical thrombectomy equipment, which requires significant capital expenditures. The multiple compares the enterprise value (EV), including net debt, to earnings before interest, taxes, depreciation, and amortization (EBITDA), quantifying the efficiency of capital management. Analyzing the history of Inari Medical, Inc. (NARI) EV/EBITDA values allows for the determination of asset overvaluation and an assessment of growth potential amid changes in borrowing costs.